Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher Ward

Showing results (141-150 of 163) with videos related to

Pageof 17
Sort By:
Pathology|June 24, 2022
A pilot study assessing the implementation of 96-well plate-based aggregometry (Optimul) in AustraliaHannah Hsu, Melissa V Chan, Paul C Armstrong, et al.
Trials|September 16, 2022
Study protocol for the management of impacted maxillary central incisors: a multicentre randomised clinical trial: the iMAC TrialJadbinder Seehra, Andrew T DiBiase, Shruti Patel, et al.
Internal Medicine Journal|March 7, 2023
The importance of frailty assessment in multiple myeloma: a position statement from the Myeloma Scientific Advisory Group to Myeloma AustraliaShirlene Sim, Anna Kalff, Gina Tuch, et al.
BMJ Open|February 5, 2025
The effectiveness and risks of Treating people with Idiopathic Pulmonary fibrosis with the Addition of Lansoprazole (TIPAL): study protocol for a randomised placebo-controlled multicentre clinical trialMegan Jones, Anthony Cahn, Nazia Chaudhuri, et al.
Frontiers in Genetics|December 13, 2023
Personalized medicine in a community health system: the NorthShore experienceSean P David, Henry M Dunnenberger, Sarah Choi, et al.
International Journal of Radiation Oncology, Biology, Physics|November 12, 2020
Automatic Segmentation Using Deep Learning to Enable Online Dose Optimization During Adaptive Radiation Therapy of Cervical CancerBastien Rigaud, Brian M Anderson, Zhiqian H Yu, et al.
American Journal of Respiratory Cell and Molecular Biology|April 16, 2025
Succinate Chemosensing Induces CFTR-dependent Airway Clearance Which Is Impaired in Cystic FibrosisTábata Apablaza, Marisol Barros-Poblete, Livia Delpiano, et al.
Molecular Cancer Therapeutics|May 15, 2020
Preclinical Characterization of an Antibody-Drug Conjugate Targeting CS-1 and the Identification of Uncharacterized Populations of CS-1-Positive CellsRuoyan Chen, Saravanan Rajan, Michael G Overstreet, et al.
American Journal of Respiratory and Critical Care Medicine|June 23, 2020
Recombinant Acid Ceramidase Reduces Inflammation and Infection in Cystic FibrosisAaron I Gardner, Iram J Haq, A John Simpson, et al.
The Lancet. Haematology|July 18, 2025
Patient-reported outcomes with belantamab mafodotin, bortezomib, and dexamethasone versus daratumumab, bortezomib, and dexamethasone in patients with relapsed or refractory multiple myeloma (DREAMM-7): results from a phase 3, open-label, randomised controlled trialVania Hungria, Marek Hus, ChengCheng Fu, et al.
Pageof 17

Showing results (141-150 of 163) with videos related to

Sort By:
Pageof 17
Pathology|June 24, 2022
A pilot study assessing the implementation of 96-well plate-based aggregometry (Optimul) in AustraliaHannah Hsu, Melissa V Chan, Paul C Armstrong, et al.
Trials|September 16, 2022
Study protocol for the management of impacted maxillary central incisors: a multicentre randomised clinical trial: the iMAC TrialJadbinder Seehra, Andrew T DiBiase, Shruti Patel, et al.
Internal Medicine Journal|March 7, 2023
The importance of frailty assessment in multiple myeloma: a position statement from the Myeloma Scientific Advisory Group to Myeloma AustraliaShirlene Sim, Anna Kalff, Gina Tuch, et al.
BMJ Open|February 5, 2025
The effectiveness and risks of Treating people with Idiopathic Pulmonary fibrosis with the Addition of Lansoprazole (TIPAL): study protocol for a randomised placebo-controlled multicentre clinical trialMegan Jones, Anthony Cahn, Nazia Chaudhuri, et al.
Frontiers in Genetics|December 13, 2023
Personalized medicine in a community health system: the NorthShore experienceSean P David, Henry M Dunnenberger, Sarah Choi, et al.
International Journal of Radiation Oncology, Biology, Physics|November 12, 2020
Automatic Segmentation Using Deep Learning to Enable Online Dose Optimization During Adaptive Radiation Therapy of Cervical CancerBastien Rigaud, Brian M Anderson, Zhiqian H Yu, et al.
American Journal of Respiratory Cell and Molecular Biology|April 16, 2025
Succinate Chemosensing Induces CFTR-dependent Airway Clearance Which Is Impaired in Cystic FibrosisTábata Apablaza, Marisol Barros-Poblete, Livia Delpiano, et al.
Molecular Cancer Therapeutics|May 15, 2020
Preclinical Characterization of an Antibody-Drug Conjugate Targeting CS-1 and the Identification of Uncharacterized Populations of CS-1-Positive CellsRuoyan Chen, Saravanan Rajan, Michael G Overstreet, et al.
American Journal of Respiratory and Critical Care Medicine|June 23, 2020
Recombinant Acid Ceramidase Reduces Inflammation and Infection in Cystic FibrosisAaron I Gardner, Iram J Haq, A John Simpson, et al.
The Lancet. Haematology|July 18, 2025
Patient-reported outcomes with belantamab mafodotin, bortezomib, and dexamethasone versus daratumumab, bortezomib, and dexamethasone in patients with relapsed or refractory multiple myeloma (DREAMM-7): results from a phase 3, open-label, randomised controlled trialVania Hungria, Marek Hus, ChengCheng Fu, et al.
Pageof 17